Quarterly report pursuant to Section 13 or 15(d)

Share-based compensation - Equity Incentive Plan (Details)

v3.21.2
Share-based compensation - Equity Incentive Plan (Details) - Plan - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Shares available for future grant 63,353  
Number of Shares    
Outstanding at December 31, 2020 519,163  
Granted 299,984 229,984
Outstanding at September 30, 2021 749,147 519,163
Exercisable at September 30, 2021 530,977  
Weighted Average Exercise Price    
Outstanding at December 31, 2020 $ 10.00  
Granted 6.85 $ 6.85
Outstanding at September 30, 2021 9.03 $ 10.00
Exercisable at September 30, 2021 $ 9.92  
Weighted Average Remaining Contractual Term (years)    
Weighted average remaining contractual term (years) 9 years 4 months 6 days 9 years 11 months 23 days
Exercisable at September 30, 2021 9 years 2 months 26 days  
Intrinsic value of options outstanding $ 0